Prudential Jennison Health Sciences Fund Class A (PHLAX)

46.90
Net Asset Value
+1.52%
1 Day
+4.66%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
5.5
Sales Expenses
1.14%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund seeks investments whose prices will increase over time. It normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector- such as pharmaceutical companies- biotechnology companies- medical device manufacturers- healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets- revenues or profits from operations in the healthcare sector. The fund is non-diversified.

Performance

1 month-4.29% 3 years+3.43%
3 months+7.99% 5 years+18.30%
1 year+21.41% Since inception+15.89%
Data through --

Peer Comparisonvs. Health

 PHLAXCategory
Performance 5-yr return+18.30%+17.28%
Expense ratio1.14%1.31%
Risk 5 year sharpe ratio0.961.11
Net assets$2.4B$3.2B
Average market cap$12.3B$9.5B
Average P/E--22.6
Portfolio turnover27%27%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPrudential Funds (PGIM Investments)
Fund manager & tenureDavid Chan / 18 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock96.36%
International stock3.08%
Fixed income0.41%
Other0.14%
Cash0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 97.95%
Consumer service 1.34%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
UNH UnitedHealth6.85%
BMRN Biomarin Pharmaceutical Inc5.42%
SAGE SAGE Therapeutics Inc4.28%
HUM Humana Inc4.11%
BLUE bluebird bio Inc3.93%
CI Cigna Corp3.33%
AGN Allergan3.21%
ILMN Illumina Inc3.19%
ASMB Assembly Biosciences Inc3.05%
AET Aetna2.70%